“…Although lipid peroxidation has been reported to be raised in hemodialysis patients, most studies have used the thiobarbituric acid test, which is known to have low specificity and to produce artefacts when applied to body fluids [13, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38]. Despite the claim this test evaluates lipid peroxidation by measuring only malonaldehyde, a hydroperoxide degradation product [39], it also reacts with many other components, among them amino acids, sugar, biliverdin, hemoglobin, prostaglandin, thromboxanes, therapeutics agents, and even urea [40, 41, 42, 43, 44].…”